Search
for
Sort by
Research 301–330 of 795
- Beyond Counting Sheep: Exploring the Link between Polycystic Ovary Syndrome and Sleep Health
- Treatment of Hirsutism With Spironolactone
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- Relative Safety and Efficacy of Finasteride for Treatment of Hirsutism
- Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients
- Development of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ)
- Testosterone- and Cortisol-Secreting Adrenocortical Oncocytoma: An Unusual Cause of Hirsutism
- ANDROGENETIC ALOPECIA
- Alopecia and hirsutism*
- Effectiveness and safety of triple-diode laser with or without adjunctive topical eflornithine in female hirsutism
- Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies
- Hair: A Review of Prominent Scalp Hair Changes throughout a Females’ Life
- Alopecia and its medical management
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Is prostate-specific antigen a potential new marker of androgen excess in polycystic ovary syndrome?
- Management of Hirsutism Associated With Obese PCOD - A Case Report
- CUTANEOUS MANIFESTATIONS OF POLYCYSTIC OVARIAN DISEASE
- The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review
- Polycystic Ovary Syndrome (PCOS) and Other Androgen Excess–Related Conditions: Can Changes in Dietary Intake Make a Difference?
- Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare
- TRICHOPATHOPHOBIA.
- A Novel Point Mutation in the Ligand-Binding Domain (LBD) of the Human Glucocorticoid Receptor (hGR) Causing Generalized Glucocorticoid Resistance: The Importance of the C Terminus of hGR LBD in Conferring Transactivational Activity
- Hirsutism: Diagnosis and management
- Carriers of 21-Hydroxylase Deficiency Are Not at Increased Risk for Hyperandrogenism*
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Mood disorders and quality of life in polycystic ovary syndrome
- Polycystic ovary syndrome: A review for dermatologists
- Hirsutism: diagnosis and treatment
- Validation of Chinese Version of Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (Chi-PCOSQ)
- Treatment of androgen excess in females: Yesterday, today and tomorrow